Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Amifostine is a pro-drug which is activated to the free thiol metabolite at the tissue site. The thiol metabolite is responsible for most of the cytoprotective and radioprotective properties of amifostine. It is readily taken up by cells where it binds to and detoxifies reactive metabolites of platinum and alkylating agents as well as scavenges free radicals. Other possible effects include inhibition of apoptosis, alteration of gene expression and modification of enzyme activity. Healthy cells are preferentially protected because amifostine and metabolites are present in healthy cells at 100-fold greater concentrations than in tumour cells.
Amifostine shows a good effect in reducing harmful effects of cisplatin chemotherapy on kidneys in women treated for advanced ovarian cancer as well as relieving dry mouth problems (xerostomia) with head and neck cancer patients undergoing radiation treatment. It is estimated that the amifostine market will keep an upward tendency.
The prevalence of target diseases, the increasing demand for early detection of incurable diseases and the emergence of innovative applications, the market of amifostine is rapidly developing, people's preference for instant testing and personalized drugs is growing, and cost-effective laboratory testing And the emergence of integrated analysis systems is expected to bring new opportunities to businessmen in this market.
The report details the trend, potential and market size of Amifostine market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Amifostinemarket, defines the market attractiveness level of Amifostine market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Amifostine industry, describes the types of Amifostine market, the applications of major players and the market size, and deeply analyzes the current situation of the global Amifostine market and the development prospects and opportunities of Amifostine industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Amifostine market in Chapter 13.
By Player:
Luye Pharma
Taj Pharmaceuticals
Mingren Pharma
Clinigen Group
Merro Pharmaceutical
Sun Pharmaceutical
By Type:
400mg/Dose
500mg/Dose
By End-User:
Ovarian Cancer Adjuvant Therapy
Head and Neck Cancer Adjuvant Therapy
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Amifostine Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Amifostine Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Amifostine Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Amifostine Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Amifostine Market Analysis and Outlook to 2022
-
7.1 Global Amifostine Consumption (2017-2022)
-
7.2 United States Amifostine Consumption (2017-2022)
-
7.3 Europe Amifostine Consumption (2017-2022)
-
7.4 China Amifostine Consumption (2017-2022)
-
7.5 Japan Amifostine Consumption (2017-2022)
-
7.6 India Amifostine Consumption (2017-2022)
-
7.7 South Korea Amifostine Consumption (2017-2022)
8 Region and Country-wise Amifostine Market Analysis and Outlook to 2028
-
8.1 Global Amifostine Consumption Forecast (2022-2028)
-
8.2 United States Amifostine Consumption Forecast (2022-2028)
-
8.3 Europe Amifostine Consumption Forecast (2022-2028)
-
8.4 China Amifostine Consumption Forecast (2022-2028)
-
8.5 Japan Amifostine Consumption Forecast (2022-2028)
-
8.6 India Amifostine Consumption Forecast (2022-2028)
-
8.7 South Korea Amifostine Consumption Forecast (2022-2028)
9 Global Amifostine Market Outlook by Types and Applications to 2022
-
9.1 Global Amifostine Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 400mg/Dose Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 500mg/Dose Consumption and Growth Rate (2017-2022)
-
9.2 Global Amifostine Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Ovarian Cancer Adjuvant Therapy Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Head and Neck Cancer Adjuvant Therapy Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Amifostine Market Outlook by Types and Applications to 2028
-
10.1 Global Amifostine Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global 400mg/Dose Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global 500mg/Dose Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Amifostine Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Ovarian Cancer Adjuvant Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Head and Neck Cancer Adjuvant Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Amifostine Import and Export Analysis (Top 5 Countries)
-
11.1 Global Amifostine Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Amifostine Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Amifostine Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Amifostine Market Competitive Analysis
-
14.1 Luye Pharma
-
14.1.1 Luye Pharma Company Details
-
14.1.2 Luye Pharma Amifostine Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Luye Pharma Amifostine Product and Service
-
14.2 Taj Pharmaceuticals
-
14.2.1 Taj Pharmaceuticals Company Details
-
14.2.2 Taj Pharmaceuticals Amifostine Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Taj Pharmaceuticals Amifostine Product and Service
-
14.3 Mingren Pharma
-
14.3.1 Mingren Pharma Company Details
-
14.3.2 Mingren Pharma Amifostine Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Mingren Pharma Amifostine Product and Service
-
14.4 Clinigen Group
-
14.4.1 Clinigen Group Company Details
-
14.4.2 Clinigen Group Amifostine Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Clinigen Group Amifostine Product and Service
-
14.5 Merro Pharmaceutical
-
14.5.1 Merro Pharmaceutical Company Details
-
14.5.2 Merro Pharmaceutical Amifostine Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Merro Pharmaceutical Amifostine Product and Service
-
14.6 Sun Pharmaceutical
-
14.6.1 Sun Pharmaceutical Company Details
-
14.6.2 Sun Pharmaceutical Amifostine Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Sun Pharmaceutical Amifostine Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Amifostine
-
Figure Amifostine Picture
-
Table Global Amifostine Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Amifostine Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Amifostine Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Amifostine Consumption by Country (2017-2022)
-
Figure United States Amifostine Consumption and Growth Rate (2017-2022)
-
Table Europe Amifostine Consumption and Growth Rate (2017-2022)
-
Figure China Amifostine Consumption and Growth Rate (2017-2022)
-
Figure Japan Amifostine Consumption and Growth Rate (2017-2022)
-
Figure India Amifostine Consumption and Growth Rate (2017-2022)
-
Figure South Korea Amifostine Consumption and Growth Rate (2017-2022)
-
Figure Global Amifostine Consumption Forecast by Country (2022-2028)
-
Figure United States Amifostine Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Amifostine Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Amifostine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Amifostine Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Amifostine Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Amifostine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 400mg/Dose Consumption and Growth Rate (2017-2022)
-
Figure Global 500mg/Dose Consumption and Growth Rate (2017-2022)
-
Figure Global Ovarian Cancer Adjuvant Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Head and Neck Cancer Adjuvant Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global 400mg/Dose Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 500mg/Dose Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ovarian Cancer Adjuvant Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Head and Neck Cancer Adjuvant Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Amifostine Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Amifostine Export by Region (Top 5 Countries) (2017-2028)
-
Table Luye Pharma (Foundation Year, Company Profile and etc.)
-
Table Luye Pharma Amifostine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Luye Pharma Amifostine Product and Service
-
Table Taj Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Taj Pharmaceuticals Amifostine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Taj Pharmaceuticals Amifostine Product and Service
-
Table Mingren Pharma (Foundation Year, Company Profile and etc.)
-
Table Mingren Pharma Amifostine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mingren Pharma Amifostine Product and Service
-
Table Clinigen Group (Foundation Year, Company Profile and etc.)
-
Table Clinigen Group Amifostine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Clinigen Group Amifostine Product and Service
-
Table Merro Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Merro Pharmaceutical Amifostine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merro Pharmaceutical Amifostine Product and Service
-
Table Sun Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Sun Pharmaceutical Amifostine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sun Pharmaceutical Amifostine Product and Service
-
